Anne Reiser - ResMed Insider

RMD -- USA Stock  

USD 102.04  0.81  0.79%

President Europe

Ms. Anne Reiser is President Europe Asia Pacific of Resmed Inc. Ms. Reiser was appointed president of our Europe and Asia Pacific region in December 2014. Previously, Ms. Reiser was president of ResMeds Europe region, a position she began in March 2012. She served as our chief operating officer France beginning in 2007, after joining as the sales director in 2006. Before joining ResMed, her career experience was in the medical device industry . More recently she worked for Medtronic and Hollister, with responsibilities for both France and finally southern European countries
Age: 54  President Since 2014      
858-836-5000  http://www.resmed.com
Reiser has a master degree from Ecole Sup?rieure de Commerce de ClermontFd, and a bachelor degree of law from the University of ClermontFerrand and an executive master in management and healthcare policies from SciencesPo Paris.

Anne Reiser Latest Insider Activity

Management Efficiency

The company has Return on Asset of 9.1 % which means that on every $100 spent on asset it made $9.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.29 % implying that it generated $15.29 on every 100 dollars invested.
The company has 1.02 B in debt with debt to equity (D/E) ratio of 50.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 1.26 demonstrating that it may have difficulties to pay its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Rainer BerthanDENTSPLY SIRONA
2016
Bijoy SagarStryker Corporation
2014
Peter ValentiHologic
2014
Claus EgstrandHologic
2014
Graham McleanStryker Corporation
2017
Mike BruffVarian Medical Systems
2018
Karen PrangeBoston Scientific Corporation
2012
Karen BoylanTeleflex Incorporated
2014
Wendy CarruthersBoston Scientific Corporation
2012
Bronwen TaylorStryker Corporation
2013
Nicholas AlexosDENTSPLY SIRONA
2017
Glenn BoehnleinStryker Corporation
2016
Michael PhalenBoston Scientific Corporation
2012
Kolleen KennedyVarian Medical Systems
2014
Arthur ButcherBoston Scientific Corporation
2016
Keith DawkinsBoston Scientific Corporation
2012
Daniel McBrideThe Cooper Companies
2014
Thomas PowellTeleflex Incorporated
2013
Kevin BallingerBoston Scientific Corporation
2017
Carrie MannerQuest Diagnostics Incorporated
2017
Maureen MacInnisDENTSPLY SIRONA
2016

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people.ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 6,000 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.

ResMed Leadership Team

John Wareham, Director, MBA
Ronald Taylor, Director
Rob Douglas, President
Christopher Roberts, Director, MBA
Gary Pace, Director, Ph.D
Chris Roberts, Director, MBA
Robert Douglas, COO
Agnes Lee, Director
Carol Burt, Director
Rich Sulpizio, Director
Peter Farrell, Chairman, Ph.D
Jim Hollingshead, President, Ph.D
Brett Sandercock, CFO
Ron Taylor, Director
Don Darkin, President
Jack Wareham, Director
Anne Reiser, President
Karen Drexler, Director
Raj Sodhi, President, MBA
David Pendarvis, Executive
Richard Sulpizio, Director
Michael Farrell, CEO, MBA
Richard McHale, President
Donald Darkin, President

Stock Performance Indicators

Current Sentiment - RMD

ResMed Investor Sentiment
Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
APHQF   
Purchased over 300 shares of
few days ago
Traded for 9.556
LOB   
Purchased over 100 shares of
few days ago
Traded for 29.25
ETFC   
Purchased over 40 shares of
few days ago
Traded for 64.51
FFWC   
Purchased over 60 shares of
few days ago
Traded for 43.0
RYFL   
Purchased over 100 shares of
few days ago
Traded for 16.15
Additionally take a look at Your Equity Center. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.